Mebendazole (Vermox; Johnson & Johnson Inc, New Brunswick, NJ) is an effective antiparasite drug used for the treatment of Oxyurus vermicularis infections (oxyuriasis).1 Although theoretically considered as a well-tolerated drug with few adverse effects, we report a unique case of transient ciliochoroidal effusion that occurred in temporal association with mebendazole therapy.
Ciliochoroidal effusion syndrome associated with mebendazole systemic treatment
Pasquale Viggiano
Writing – Review & Editing
;Maria Oliva GrassiMembro del Collaboration Group
;Giuseppina MonteleoneMembro del Collaboration Group
;Silvana GuerrieroMembro del Collaboration Group
;Francesco BosciaSupervision
2022-01-01
Abstract
Mebendazole (Vermox; Johnson & Johnson Inc, New Brunswick, NJ) is an effective antiparasite drug used for the treatment of Oxyurus vermicularis infections (oxyuriasis).1 Although theoretically considered as a well-tolerated drug with few adverse effects, we report a unique case of transient ciliochoroidal effusion that occurred in temporal association with mebendazole therapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
